Filing Details
- Accession Number:
- 0001415889-21-005960
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-15 16:45:29
- Reporting Period:
- 2021-12-14
- Accepted Time:
- 2021-12-15 16:45:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1708527 | Aziyo Biologics Inc. | AZYO | Biological Products, (No Disgnostic Substances) (2836) | 474790334 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1825799 | Thomas Englese | C/O Aziyo Biologics, Inc. 12510 Prosperity Drive, Suite 370 Silver Spring MD 20904 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2021-12-14 | 4,580 | $6.10 | 5,088 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 508 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
Billionaire Hedge Funds
